Target-Based ADME/Tox Assays
 | Life Technologies offers a collection of target-based ADME/Tox assays for drug discovery and development to help you determine the metabolic and safety profiles of lead candidates on a high throughput scale. |
Featured Target-Based ADME/Tox Assay Categories
 | P450 Assays Fluorescent substrates and recombinant enzymes to evaluate your compound’s potential impact on P450 activity |  | Transporter Products GenoMembrane Transporter Vesicles and Transporter-qualified Hepatocytes to facilitate the prediction of your compounds modulation of transport enzyme activity | |
 | hERG Assays Perform cardiac safety screening with biochemical or cellular assays to identify potential hERG channel blockers |  | Nuclear Receptor ADME Assays Our LanthaScreen® PXR (SXR) and CAR Competitive Binding Assays contains all the reagents you need to conduct compound affinity testing | |
 | G-Protein Coupled Receptor Cellular ADME Assays Avoid off-target effects with our GPCR toxicity panel of validated cellular assays for selectivity screening |  | Toxicology Products Assays to identify indicators of both biochemical and cellular toxicity | |
 | PCR-Based Drug Discovery Assays Analyze drug discovery-related genes using our real-time PCR arrays |
|
|
ADME/Tox eNews
ADME/Tox News - insight into products, techniques, promotions and events |
|
ADME/Tox Resources |
Support
|
For Research Use Only. Not for use in diagnostic procedures.
